Organon & Co | OGN - Loan Capital


Organon & Co reported $8.78B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Gilead Sciences USD 22.13B 6M Dec/2025
Glaxosmithkline GBP 19.82B 203.13M Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 36.68M 1.07M Dec/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 383.14M 727K Dec/2025